Track Crystagen in Peptimes™
The Library lists Crystagen as the tripeptide Glu-Asp-Pro (EDP). A Russian patent from 2006, RU 2301074, claims the peptide H-Glu-Asp-Pro-OH. (Source: Google Patents.)
Is Crystagen FDA-approved?
No. Crystagen isn't FDA-approved, and Drugs@FDA lists no application with it as an active ingredient.
Crystagen
Also: Cristagen, Kristagen, Кристаген, EDP peptide, Glu-Asp-Pro
- Status label in the Peptimes Library
- Dietary Supplement
- Routes in Peptimes
- OralSublingualIntramuscular
- Updated
- 1 Nov 2026
US regulatory status
How to track it in Peptimes
Add Crystagen in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Dietary Supplement”. In the US it is not FDA-approved.
- Routes: oral, sublingual or intramuscular. Choose the one that matches each dose.
- Logging: the amount you took, the route and how you feel.
- Injection sites: intramuscular doses record the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next. Oral and sublingual doses skip this step.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell Crystagen or any other compound.
More sources
- Google Patents, RU 2301074, read 1 Nov 2026: a Russian patent, filed in 2006, for the peptide glutamyl-aspartyl-proline (H-Glu-Asp-Pro-OH).
- NIH, ClinicalTrials.gov, search for Crystagen, checked 1 Nov 2026: no registered study.